LOGIN  |  REGISTER
Amneal Pharmaceuticals

Augmedix (NASDAQ: AUGX) Stock Quote

Last Trade: US$4.09 0.05 1.24
Volume: 227,982
5-Day Change: 1.49%
YTD Change: -30.09%
Market Cap: US$198.610M

Latest News From Augmedix

SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three and 12 months ended December 31, 2023. “The fourth quarter was a solid end to a strong year for Augmedix both operationally and financially,” stated Augmedix CEO Manny Krakaris. “We delivered a 45% increase in revenue to $12.7 million, ahead... Read More
SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced new positive data and product enhancements for Augmedix Go , its ambient AI medical documentation product. Now supporting over 50 medical specialties, the Augmedix Go mobile app optimizes ambient AI technology to produce comprehensive draft medical notes in real time by... Read More
SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will release fourth quarter and full year 2023 results after the market closes on Monday, March 18, 2024. Following the release, management will host a conference call and audio webcast to review results and provide a... Read More
SAN FRANCISCO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that members of its management team will participate in a fireside chat and host investor meetings at the Citizens JMP Technology Conference taking place in San Francisco on March 4, 2024. The fireside chat will be held... Read More
SAN FRANCISCO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that Tomer Levy joined the company in January 2024 in the newly-created Senior Vice President of Engineering role. Levy brings over 20 years of experience in healthcare information technology. Throughout his career, he has... Read More
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC , a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 24 th , & Thursday, January 25 th , 2024, starting at 9:00 a.m. ET. We will be presenting our 2024... Read More
SAN FRANCISCO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that it will participate in the Maxim Group Virtual Healthcare IT Conference on January 24, 2024. Manny Krakaris, Chief Executive Officer, will join a fireside chat with Allen Klee, Equity Research Analyst. Details for... Read More
SAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc . (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced preliminary revenue results and operational metrics for the fourth quarter of 2023. “Augmedix’s expected fourth quarter revenue of approximately $12.5 million puts us on pace to deliver a solid finish to a strong... Read More
SAN FRANCISCO, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today that it has been piloting Google Cloud’s Med-PaLM 2 and will integrate Google Cloud’s newly introduced MedLM technology into its technology stack. This model suite uses the latest AI developments adapted for healthcare use... Read More
SAN FRANCISCO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced the closing of a registered public offering of common stock for aggregate gross proceeds of $28.75 million, prior to deducting underwriting discounts, commissions, and other offering expenses. The incremental capital,... Read More
SAN FRANCISCO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX) (“Augmedix”), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that it has priced the previously-announced underwritten public offering of 6,250,000 shares of its common stock, at a public offering price of $4.00 per share. The offering was upsized from 5,500,000... Read More
SAN FRANCISCO, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX) (“Augmedix”), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that it has commenced an underwritten public offering of 5,500,000 shares of its common stock. Augmedix intends to grant the underwriters a 30-day option to purchase an additional 15% of the shares of its... Read More
SAN FRANCISCO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, reported today financial results for the three and nine months ended September 30, 2023. “The third quarter marked another period of strong progress for Augmedix as we continue to be a leader in the large and rapidly growing ambient medical... Read More
SAN FRANCISCO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will report financial results for the third quarter ended September 30, 2023, on Monday, November 6, 2023, after the market closes. Management will host a conference call that day at 1:30 p.m. Pacific Time / 4:30 p.m.... Read More
Ellipsis Health's AI Technology Will Allow Healthcare Providers Using Augmedix to Seamlessly Screen Patients for Symptoms of Anxiety and Depression SAN FRANCISCO , Oct. 5, 2023 /PRNewswire/ -- Ellipsis Health , the market leader in AI-generated vocal biomarker technology for the identification and monitoring of mental health conditions at scale, today announced a plan for a strategic partnership with Augmedix (Nasdaq: AUGX),... Read More
SAN FRANCISCO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today that it has reached agreements in principle for strategic collaborations with three innovative digital health companies: Myndshft, Ellipsis Health, and The Sullivan Group. The goal of these partnerships is to enhance the... Read More
SAN FRANCISCO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Augmedix , a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today the early access release of the newest product on its platform, Augmedix Go , a clinician-controlled mobile app that uses generative AI to instantaneously create a fully automated draft medical note after each patient visit. Augmedix Go... Read More
SAN FRANCISCO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced the appointment of its inaugural AI Advisory Council members. The council was established to guide Augmedix’s continued development and usage of artificial intelligence (AI) throughout its business responsibly and ethically. The... Read More
SAN FRANCISCO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today the expansion of the company’s medical documentation products to the behavioral healthcare field. As the need for behavioral healthcare continues to grow , Augmedix is proud to successfully serve the behavioral health field... Read More
SAN FRANCISCO, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that they have earned certified status by HITRUST for information security covering their core products, Augmedix Live and Augmedix Notes, as well as the cloud services supporting these products. HITRUST risk-based, two-year... Read More
SAN FRANCISCO, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced that it will participate in the following investor conferences during September 2023. Wells Fargo Healthcare Conference, September 6-8,... Read More
SAN FRANCISCO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and six months ended June 30, 2023. “This was another strong quarter for Augmedix, as we continue to... Read More
SAN FRANCISCO, July 28, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced it will report financial results for the second quarter ended June 30, 2023, on Monday, August 7, 2023, after the market closes. Company... Read More
SAN FRANCISCO, June 14, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation, today announced that it has amended its existing senior secured term loan facility with Silicon Valley Bank (“SVB”), a division of First Citizens Bank, which may extend the interest only period by as long as 18 months from January 2024 to July 2025, and... Read More
SAN FRANCISCO, June 12, 2023 (GLOBE NEWSWIRE) -- Augmedix , a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today the establishment of an AI Advisory Council. The healthcare industry’s adoption of AI is growing very rapidly and Augmedix is committed to harnessing the power of AI thoughtfully and responsibly to provide its customers with solutions... Read More
SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced that its leadership team will attend the following investor conferences during May and June 2023. B. Riley 23 rd Annual Institutional Investor... Read More
SAN FRANCISCO, May 12, 2023 (GLOBE NEWSWIRE) - - Augmedix ( Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three months ended March 31, 2023. “Augmedix begins 2023 with continued commercial momentum, increasing operating... Read More
SAN FRANCISCO, May 08, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced it will report financial results for the first quarter ended March 31, 2023, on Friday, May 12, 2023, before the market opens. Company management will... Read More
SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation, today announced a partnership with HCA Healthcare, Inc. (NYSE: HCA), one of the nation's leading healthcare providers, to accelerate development of technology that aims to transform the way patient care is documented in the acute care setting. Augmedix will... Read More
Company raises $12 million of new equity from HCA Healthcare and Redmile Group; Augmedix and HCA Healthcare to collaborate on AI-powered ambient documentation products for the acute care setting; Provides sufficient capital to achieve cash flow sustainability SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers ambient medical documentation and data... Read More
SAN FRANCISCO, March 27, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leading provider of ambient medical documentation and data solutions delivered remotely to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and 12 months ended December 31, 2022. “We finished 2022 with our best-ever fourth quarter in terms of bookings, with sales... Read More
SAN FRANCISCO, March 16, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced it will report financial results for the fourth quarter and full-year ended December 31, 2022 on Monday, March 27, 2023, before the market opens. Company management will host a conference call that day at 5:00 a.m.... Read More
SAN FRANCISCO, March 07, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that Manny Krakaris, Chief Executive Officer, and Paul Ginocchio, Chief Financial Officer will attend and present at the Oppenheimer 33 rd Annual Healthcare Conference taking place virtually on March 13 – 15, 2023.... Read More
SAN FRANCISCO, March 01, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that Rod O'Reilly has been named to the Augmedix Board of Directors as non-executive chairman. One of the most influential executives in healthcare technology, Mr. O’Reilly brings unmatched experience and relationships... Read More
SAN FRANCISCO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that management will attend the Third Annual Winter Wonderland Best Ideas Conference taking place virtually on February 21 - 24, 2023. Manny Krakaris, Chief Executive Officer, will participate in a live fireside chat... Read More
SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that its leadership team will participate in the Maxim Group Virtual Healthcare IT Conference on Wednesday, January 25, 2023. Manny Krakaris, Chief Executive Officer, will join the “Doctors Panel” which will be webcast... Read More
SAN FRANCISCO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced preliminary financial results and operational metrics for the fourth quarter of 2022. “Augmedix generated strong bookings in the fourth quarter and we expect revenue to be within our guidance range of $8.5 million to... Read More
C4 Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB